Characterization of the interleukin 1 receptor-associated kinase 4 (IRAK4)-encoding gene in salmonid fish: The functional copy is rearranged in Oncorhynchus mykiss and that factor can impair TLR signaling in mammalian cells

被引:36
|
作者
Brietzke, Andreas [1 ]
Goldammer, Tom [1 ]
Rebl, Henrike [2 ]
Korytar, Tomas [3 ]
Koellner, Bernd [3 ]
Yang, Wei [4 ]
Rebl, Alexander [1 ]
Seyfert, Hans-Martin [1 ]
机构
[1] Leibniz Inst Farm Anim Biol, Inst Genome Biol, D-18196 Dummerstorf, Germany
[2] Univ Rostock, Dept Cell Biol, Med Ctr, D-18057 Rostock, Germany
[3] Friedrich Loeffler Inst FLI, Inst Immunol, Fed Res Inst Anim Hlth, D-17493 Greifswald, Insel Riems, Germany
[4] Duke Univ, Dept Anesthesiol, Med Ctr, Durham, NC 27710 USA
关键词
Aeromonas salmonicida; Innate immunity; Myddosome; Rainbow trout; Toll-like receptor; NF-KAPPA-B; TOLL-LIKE RECEPTORS; INNATE; IRAK-4; EXPRESSION; ACTIVATION; FAMILY; RECOGNITION; INDUCTION; ALPHA;
D O I
10.1016/j.fsi.2013.11.005
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
The interleukin 1 receptor-associated kinase 4 (IRAK4) is an essential factor for TLR-mediated activation of the host's immune functions subsequent to pathogen contact. We have characterized the respective cDNA and gene sequences from three salmonid species, salmon, rainbow trout and maraena whitefish. The gene from salmon is structured into eleven exons, as is the mammalian homologue, while exons have been fused in the genes from the two other salmonid species. Rainbow trout expresses also a pseudogene at low levels. Its basic structure resembles more closely the primordial gene than the functional copy does. The N-terminal death domain and the C-terminal protein kinase domain of the factors are better conserved throughout evolution than the linker domain. The deduced amino acid sequences of the factors from all three species group together in an evolutionary tree of IRAK4 factors. Scrutinizing expression and function of IRAK4 from rainbow trout, we found its highest expression in head kidney and spleen and lowest expression in muscle tissue. Infecting fish with Aeromonas salmonicida did not modulate its expression during 72 h of observation. Expression of a GFP-tagged trout IRAK4 revealed, expectedly, its cytoplasmic localization in human HEK-293 cells. However, this factor significantly quenched in a dose-dependent fashion not only the pathogen-induced stimulation of NF-kappa B factors in the HEK-293 reconstitution system of TLR2 signaling, but also the basal NF-kappa B levels in unstimulated control cells. Our data unexpectedly imply that IRAK4 is involved in establishing threshold levels of active NF-kappa B in resting cells. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:206 / 214
页数:9
相关论文
共 14 条
  • [1] Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling
    De Nardo, Dominic
    Balka, Katherine R.
    Gloria, Yamel Cardona
    Rao, Vikram R.
    Latz, Eicke
    Masters, Seth L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (39) : 15195 - 15207
  • [2] Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4)
    Wang, Li
    Ferrao, Ryan
    Li, Qiubai
    Hatcher, John M.
    Choi, Hwan Geun
    Buhrlage, Sara J.
    Gray, Nathanael S.
    Wu, Hao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (12) : 4511 - 4519
  • [3] Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018)
    McElroy, William T.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (04) : 243 - 259
  • [4] Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
    Lin, Yaoxiang
    Zheng, Lulu
    Xu, Ying
    Wang, Xinyan
    Li, Jie
    Zheng, Lei
    Liang, Guang
    Chen, Lingfeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 902 - 914
  • [5] Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015)
    Seganish, W. Michael
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (08) : 917 - 932
  • [6] Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
    Feng, Yifan
    Chen, Chengjuan
    Shao, Anqi
    Wu, Lei
    Hu, Haiyu
    Zhang, Tiantai
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (12) : 5091 - 5105
  • [7] Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway
    Shi, Min
    Deng, Yilin
    Yu, Heguo
    Xu, Ling
    Shi, Cuicui
    Chen, Jiong
    Li, Guangming
    Du, Yiqi
    Wang, Yu-gang
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [8] Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
    Chaudhary, Divya
    Robinson, Shaughnessy
    Romero, Donna L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 96 - 110
  • [9] A mammalian like interleukin-1 receptor-associated kinase 4 (IRAK-4), a TIR signaling mediator in intestinal innate immunity of black tiger shrimp (Penaeus monodon)
    Watthanasurorot, Apiruck
    Soderhall, Kenneth
    Jiravanichpaisal, Pikul
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (01) : 623 - 629
  • [10] Interleukin-1 receptor-associated kinase 4 (IRAK4) in the nucleus accumbens regulates opioid-seeking behavior in male rats
    Wu, Ruyan
    Liu, Jianfeng
    Vu, Jimmy
    Huang, Yufei
    Dietz, David M.
    Li, Jun-Xu
    BRAIN BEHAVIOR AND IMMUNITY, 2022, 101 : 37 - 48